CIK 0001601830
- Large accelerated filer
RECURSION PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- RXRX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 464099738
- Phone
- +1 385-269-0203
- Business address
- 41S RIO GRANDE STREET, SALT LAKE CITY, UT, 84101
- Former names
- Recursion Pharmaceuticals, LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $701,222
- in 5 filings, $701K under 10b5-1 plans
Net −$701,222. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-07-12 | Burrell Terry-Ann Director | Sale | −24,302 | $11.25 | $273K | 147,545 |
| 2023-07-12 | Burrell Terry-Ann Director | Sale | −78,071 | $12.15 | $948K | 69,474 |
| 2023-07-12 | Burrell Terry-Ann Director | Sale | −3,195 | $13.18 | $42K | 66,279 |
| 2023-07-12 | Burrell Terry-Ann Director | Sale | −3,157 | $14.08 | $44K | 63,122 |
| 2023-07-11 | Borgeson Blake Director | Sale | −8,885 | $6.89 | $61K | 7,520,104 |
| 2023-07-03 | Li Dean Y Director | Grant or award | +1,609 | 637,461 | ||
| 2023-07-03 | Dar Zavain Director | Grant or award | +1,863 | 72,044 | ||
| 2023-07-03 | CHAVEZ R. MARTIN Director | Grant or award | +2,541 | 53,558 | ||
| 2023-07-03 | Bogue Zachary Director | Grant or award | +1,440 | 9,378 | ||
| 2023-06-29 | Borgeson Blake Director | Gift | −14,000 | 7,506,104 | ||
| 2023-06-29 | Larson Tina Marriott President and COO | Exercise or conversion 10b5-1 | +3,000 | $1.06 | $3K | 427,160 |
| 2023-06-29 | Larson Tina Marriott President and COO | Sale 10b5-1 | −3,000 | $7.49 | $22K | 424,160 |
| 2023-06-29 | Larson Tina Marriott President and COO | Exercise or conversion · Stock Option (Right to Buy) 10b5-1 | −3,000 | 540,000 | ||
| 2023-06-27 | Borgeson Blake Director | Sale | −8,885 | $7.39 | $66K | 7,528,989 |
| 2023-06-16 | Borgeson Blake Director | Grant or award | +12,612 | 7,537,874 | ||
| 2023-06-16 | Borgeson Blake Director | Grant or award · Stock Option (Right to Buy | +25,224 | 25,224 | ||
| 2023-06-16 | Li Dean Y Director | Grant or award | +12,612 | 636,021 | ||
| 2023-06-16 | Li Dean Y Director | Grant or award · Stock Option (Right to Buy) | +25,224 | 25,224 | ||
| 2023-06-16 | Dar Zavain Director | Grant or award | +12,612 | 70,181 | ||
| 2023-06-16 | Dar Zavain Director | Grant or award · Stock Option (Right to Buy) | +25,224 | 25,224 |
Page 37 of 41 · 805 trades